Managing high blood pressure and cholesterol together is crucial for heart health but often challenging. A new study highlights a promising solution: Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR).
This combination targets both conditions—Telmisartan and Amlodipine lower blood pressure, while Rosuvastatin reduces cholesterol. Together, they work more effectively than treating each condition separately.
The research shows TAR can significantly improve heart health, reducing risks like heart attacks and strokes. It offers a balanced and comprehensive approach to managing these common conditions.
